Laura Schäkel

616 total citations
12 papers, 201 citations indexed

About

Laura Schäkel is a scholar working on Physiology, Organic Chemistry and Immunology. According to data from OpenAlex, Laura Schäkel has authored 12 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Physiology, 4 papers in Organic Chemistry and 4 papers in Immunology. Recurrent topics in Laura Schäkel's work include Adenosine and Purinergic Signaling (8 papers), Peptidase Inhibition and Analysis (3 papers) and Computational Drug Discovery Methods (3 papers). Laura Schäkel is often cited by papers focused on Adenosine and Purinergic Signaling (8 papers), Peptidase Inhibition and Analysis (3 papers) and Computational Drug Discovery Methods (3 papers). Laura Schäkel collaborates with scholars based in Germany, Canada and Switzerland. Laura Schäkel's co-authors include Christa E. Müller, Julie Pelletier, Jean Sévigny, Vigneshwaran Namasivayam, Katharina Sylvester, Thanigaimalai Pillaiyar, Dominik Thimm, Jochen Bodem, Anke C. Schiedel and Michael Gütschow and has published in prestigious journals such as Angewandte Chemie International Edition, Journal of Medicinal Chemistry and Frontiers in Immunology.

In The Last Decade

Laura Schäkel

12 papers receiving 199 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Laura Schäkel Germany 7 79 64 64 54 51 12 201
Shri Niwas United States 8 64 0.8× 223 3.5× 29 0.5× 87 1.6× 99 1.9× 18 329
Nina Geiger Germany 7 9 0.1× 124 1.9× 73 1.1× 119 2.2× 38 0.7× 12 260
Christopher J. Yarnold United Kingdom 7 8 0.1× 119 1.9× 29 0.5× 61 1.1× 98 1.9× 9 270
Emma Rose Scaletti Sweden 7 68 0.9× 108 1.7× 4 0.1× 15 0.3× 36 0.7× 15 193
Henry Ji United States 9 5 0.1× 75 1.2× 68 1.1× 101 1.9× 34 0.7× 21 239
Michael T. Leininger United States 9 28 0.4× 70 1.1× 10 0.2× 8 0.1× 24 0.5× 9 248
Nahid Rahman United Kingdom 8 28 0.4× 91 1.4× 9 0.1× 21 0.4× 4 0.1× 11 196
Erol C. Vatansever United States 10 5 0.1× 150 2.3× 147 2.3× 162 3.0× 83 1.6× 12 329
Saisai Guo China 11 4 0.1× 127 2.0× 40 0.6× 98 1.8× 35 0.7× 18 290
Silvia Martinelli Germany 2 26 0.3× 94 1.5× 14 0.2× 122 2.3× 4 0.1× 5 276

Countries citing papers authored by Laura Schäkel

Since Specialization
Citations

This map shows the geographic impact of Laura Schäkel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Laura Schäkel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Laura Schäkel more than expected).

Fields of papers citing papers by Laura Schäkel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Laura Schäkel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Laura Schäkel. The network helps show where Laura Schäkel may publish in the future.

Co-authorship network of co-authors of Laura Schäkel

This figure shows the co-authorship network connecting the top 25 collaborators of Laura Schäkel. A scholar is included among the top collaborators of Laura Schäkel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Laura Schäkel. Laura Schäkel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Schäkel, Laura, Riekje Winzer, Julie Pelletier, et al.. (2025). Synthesis, Characterization, Interactions, and Immunomodulatory Function of Ectonucleotidase CD39/CD73 Inhibitor 8-Butylthioadenosine 5′-Monophosphate. ACS Pharmacology & Translational Science. 8(5). 1401–1415. 1 indexed citations
2.
Schäkel, Laura, Nadine Krüger, Katharina Sylvester, et al.. (2024). Nonpeptidic Irreversible Inhibitors of SARS-CoV-2 Main Protease with Potent Antiviral Activity. Journal of Medicinal Chemistry. 67(17). 14986–15011. 5 indexed citations
3.
Schuh, Harald, Michael Schmidt, Katharina Sylvester, et al.. (2023). Heparins are potent inhibitors of ectonucleotide pyrophosphatase/phospho-diesterase-1 (NPP1) – a promising target for the immunotherapy of cancer. Frontiers in Immunology. 14. 1173634–1173634. 6 indexed citations
4.
Schäkel, Laura, Katharina Sylvester, Julie Pelletier, et al.. (2023). Synthesis and structure–activity relationships of ticlopidine derivatives and analogs as inhibitors of ectonucleotidase CD39. Bioorganic Chemistry. 135. 106460–106460. 6 indexed citations
5.
Schäkel, Laura, Riekje Winzer, Julie Pelletier, et al.. (2022). Protein kinase inhibitor ceritinib blocks ectonucleotidase CD39 – a promising target for cancer immunotherapy. Journal for ImmunoTherapy of Cancer. 10(8). e004660–e004660. 20 indexed citations
6.
Pillaiyar, Thanigaimalai, Laura Schäkel, Nina Geiger, et al.. (2021). Die Hauptprotease von SARS‐CoV‐2 als Zielstruktur: Von der Etablierung eines Hochdurchsatz‐Screenings zum Design maßgeschneiderter Inhibitoren. Angewandte Chemie. 133(18). 10515–10521. 3 indexed citations
7.
Pillaiyar, Thanigaimalai, Laura Schäkel, Nina Geiger, et al.. (2021). Targeting the Main Protease of SARS‐CoV‐2: From the Establishment of High Throughput Screening to the Design of Tailored Inhibitors. Angewandte Chemie International Edition. 60(18). 10423–10429. 89 indexed citations
8.
Schäkel, Laura, Harald Schuh, Michael Stenbæk Schmidt, et al.. (2021). Sulfated Polysaccharides from Macroalgae Are Potent Dual Inhibitors of Human ATP-Hydrolyzing Ectonucleotidases NPP1 and CD39. Marine Drugs. 19(2). 51–51. 9 indexed citations
9.
Schäkel, Laura, Markus Pietsch, Katharina Sylvester, et al.. (2021). 2‐Substituted thienotetrahydropyridine derivatives: Allosteric ectonucleotidase inhibitors. Archiv der Pharmazie. 354(12). e2100300–e2100300. 6 indexed citations
10.
Baqi, Younis, Laura Schäkel, Enas M. Malik, et al.. (2020). Development of Anthraquinone Derivatives as Ectonucleoside Triphosphate Diphosphohydrolase (NTPDase) Inhibitors With Selectivity for NTPDase2 and NTPDase3. Frontiers in Pharmacology. 11. 1282–1282. 13 indexed citations
11.
Schäkel, Laura, Sang-Yong Lee, Julie Pelletier, et al.. (2020). Nucleotide Analog ARL67156 as a Lead Structure for the Development of CD39 and Dual CD39/CD73 Ectonucleotidase Inhibitors. Frontiers in Pharmacology. 11. 1294–1294. 29 indexed citations
12.
Schäkel, Laura, Yulu Wang, Ingo G.H. Schmidt‐Wolf, et al.. (2020). Fluorescent Probes for Ecto-5′-nucleotidase (CD73). ACS Medicinal Chemistry Letters. 11(11). 2253–2260. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026